Media Reports-Nanjing Immunophage Biotech Co.,Ltd

CN

Mar 21, 2023

Immunophage's Second-Tier Global Innovative Drug for IBD Treatment Receives Clinical Trial Approval from the U.S. FDA

1

上一页 1/1 下一页

About
Pipeline
- IPG1094 IPGA09
- IPG7236 IPGA06
- IPG0521 IPGA17
- IPG11406 IPG017
- IPG8294 IPG023
- IPG6620 IPGA12
Publications
- Paper
- Patent
News
- Press Release
- Media Reports
Careers
- Join Us

Cpyright © 2023 Nanjing Immunophage Biotech Co.,Ltd All Rights Reserved.